Standardization of Preanalytical Factors for Minimal Residual Disease Analysis in Chronic Myelogenous Leukemia

Publisher： Karger

E-ISSN： 1421-9662|112|1-2|30-33

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.1-2, 2004-06, pp. : 30-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

Detection of Minimal Residual Disease in a Patient Having Acute Myelogenous Leukemia with t(16;21)(p11;q22) Treated by Allogeneic Bone Marrow Transplantation

By  

Acta Haematologica, Vol. 105, Iss. 1, 2001-04 ,pp. : 45-48

Karger

Access to resources Recommend Favorite

Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

By  

Acta Haematologica, Vol. 135, Iss. 3, 2015-11 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Analysis of Neurofibromatosis Type 1 Gene Mutation in Juvenile Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 100, Iss. 1, 1998-08 ,pp. : 22-25

Karger

Access to resources Recommend Favorite

Immunological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 442-448

Karger

Access to resources Recommend Favorite